Company profile
NanoMedSyn
NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors
- Industry
- Biotechnology
- Employees
- 4
- Headquarters
- Montpellier
- Founded
- 2012
- Office locations
- 1
NanoMedSyn company summary
NanoMedSyn is a company in the Biotechnology industry, headquartered in Montpellier, founded in 2012. On LinkedIn the company has around 4 employees. Its listed specialties include therapeutis targeting, lysosomal storage diseases, therapeutic antibodies, nanoparticles adressing.
What technology does NanoMedSyn use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NanoMedSyn
NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism. NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA. The main application is the engineering of recombinant proteins like antibodies or enzymes for better therapies.
Specialties
Where is NanoMedSyn located?
NanoMedSyn lists 1 location.
Compare companies similar to NanoMedSyn
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NanoMedSyn nanomedsyn.com | Biotechnology | 4 | 2012 | Montpellier |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about NanoMedSyn
What does NanoMedSyn do?
NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism. NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA. The main application is the engineering of recombinant proteins like antibodies or enzymes for better therapies.
How many employees does NanoMedSyn have?
NanoMedSyn has around 4 employees on LinkedIn.
Where is NanoMedSyn headquartered?
NanoMedSyn is headquartered in Montpellier.
When was NanoMedSyn founded?
NanoMedSyn was founded in 2012.
Build a lead list from companies like NanoMedSyn
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.